Vnitr Lek 2015, 61(1):8-9

POET2 - editorial

Eva Račická
Diabetologická a interní ambulance, MUDr. Račická, s.r.o., Ostrava

Received: August 22, 2014; Published: January 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Račická E. POET2 - editorial. Vnitr Lek. 2015;61(1):8-9.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. International Diabetes Foundation. Diabetes Atlas. 5th ed. 2011. Dostupné z WWW: <http://www.idf.org/diabetesatlas/5e/theglobal-burden.Accessed10January2012>.
    2. U.K. Prospective Diabetes Study Group. UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. Diabetes Care 1998; 21(1): 87-92. Go to original source... Go to PubMed...
    3. Wright A, Burden AC, Paisey RB et al. U.K. Prospective Diabetes Study Group. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002; 25(2): 330-336. Go to original source... Go to PubMed...
    4. Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association and the European Association for the Study of Diabetes (EASD). Diabetologia 2012; 55(6): 1577-1596. Go to original source... Go to PubMed...
    5. Gerstein HC, Bosch J, Dagenais GR et al. Origin Trial Investigators. Basal insulin and cardiovascular and other outcomes in dysglycemia N Engl J Med 2012; 367(4): 319-328. Go to original source... Go to PubMed...
    6. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular event. Diabetes Care 2010; 33(6): 1389-1394. Go to original source... Go to PubMed...
    7. Peyrot M, Barnett AH, Meneghini LF et al. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy Study. Diabet Med 2012; 29(5): 682-689. Go to original source... Go to PubMed...
    8. Horák P. Farmakoekonomika léčby diabetu - trendy u nás. Vnitř Lék 2009; 55(4): 331-340. Go to PubMed...
    9. Kruntorádová K, Suchánková E, Klimeš J et al. Náklady na hypoglykemické stavy u pacientů s diabetes mellitus: cost-of-illness studie. Farmakoekonomika 2012; 6(1): 17-21.
    10. Kvapil M, Janíčkova Žďárská D, Suchopár J et al. Registr POET2: Srovnání přímých ročních zdravotnických nákladů na léčbu diabetu 2. typu po zahájení léčby inzulinem NPH nebo inzulinem glargin v kombinaci s perorálními antidiabetiky v České republice. Vnitř Lék 2015; 61(1): 24-32. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.